BG106235A - Производни на стрептограмини, тяхното получаване и състави, които ги съдържат - Google Patents

Производни на стрептограмини, тяхното получаване и състави, които ги съдържат

Info

Publication number
BG106235A
BG106235A BG106235A BG10623501A BG106235A BG 106235 A BG106235 A BG 106235A BG 106235 A BG106235 A BG 106235A BG 10623501 A BG10623501 A BG 10623501A BG 106235 A BG106235 A BG 106235A
Authority
BG
Bulgaria
Prior art keywords
preparation
radical
compositions containing
streptogramin derivatives
hydrogen atom
Prior art date
Application number
BG106235A
Other languages
English (en)
Other versions
BG65786B1 (bg
Inventor
Daniel Achard
Eric Bacque
Jean-Claude Barriere
Jean Bouquerel
Pascal Desmazeau
Serge Grisoni
Jean-Pierre Leconte
Yves Ribeill
Baptiste Ronan
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG106235(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG106235A publication Critical patent/BG106235A/bg
Publication of BG65786B1 publication Critical patent/BG65786B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06182—Dipeptides with the first amino acid being heterocyclic and Pristinamycin II; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Изобретението се отнася до производни от група настрептограмините, както и до техни соли с обща формула@@в която R1 представлява халогенен атом или азидо или тиоцианатен радикал, R2 е водороден атомили метилов или етилов радикал, R3 е водороден атом или остатък от алифатен, циклоалифатен, ароматен, аралифатен, хетероцикличен, или хетероцикличноалифатен естер, който може да бъде заместен, връзката ---- представлява една проста връзка (стереохимия 27 R) или една двойна връзка.
BG106235A 1999-06-30 2001-12-19 Производни на стрептограмини, тяхното получаване и състави, които ги съдържат BG65786B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908375A FR2795733B1 (fr) 1999-06-30 1999-06-30 Derives de streptogramines, leur preparation et les compositions qui les contiennent
PCT/FR2000/001818 WO2001002427A1 (fr) 1999-06-30 2000-06-29 Derives de streptogramines, leur preparation et les compositions qui les contiennent

Publications (2)

Publication Number Publication Date
BG106235A true BG106235A (bg) 2002-08-30
BG65786B1 BG65786B1 (bg) 2009-11-30

Family

ID=9547496

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106235A BG65786B1 (bg) 1999-06-30 2001-12-19 Производни на стрептограмини, тяхното получаване и състави, които ги съдържат

Country Status (37)

Country Link
US (2) US6569854B1 (bg)
EP (1) EP1187847B1 (bg)
JP (1) JP4585728B2 (bg)
KR (1) KR100742035B1 (bg)
CN (2) CN100543032C (bg)
AP (1) AP1392A (bg)
AR (2) AR029758A1 (bg)
AT (1) ATE255592T1 (bg)
AU (1) AU781923B2 (bg)
BG (1) BG65786B1 (bg)
BR (1) BRPI0012032B1 (bg)
CA (1) CA2376698C (bg)
CZ (1) CZ301048B6 (bg)
DE (1) DE60006958T2 (bg)
DK (1) DK1187847T3 (bg)
EA (1) EA005199B1 (bg)
EE (1) EE04683B1 (bg)
ES (1) ES2207535T3 (bg)
FR (1) FR2795733B1 (bg)
GE (1) GEP20063972B (bg)
HR (1) HRP20010937B1 (bg)
HU (1) HUP0201692A3 (bg)
IL (2) IL146185A0 (bg)
MA (1) MA26802A1 (bg)
MX (1) MXPA01012807A (bg)
NO (1) NO329456B1 (bg)
NZ (1) NZ516100A (bg)
OA (1) OA11979A (bg)
PT (1) PT1187847E (bg)
RS (1) RS50138B (bg)
SI (1) SI1187847T1 (bg)
SK (1) SK285605B6 (bg)
TN (1) TNSN00145A1 (bg)
TR (1) TR200103829T2 (bg)
UA (1) UA71619C2 (bg)
WO (1) WO2001002427A1 (bg)
ZA (1) ZA200110150B (bg)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775288B1 (fr) * 1998-02-26 2000-03-31 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositons qui les contiennent
FR2795733B1 (fr) * 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
US7232799B2 (en) 2000-12-21 2007-06-19 Aventis Pharma Sa Streptogramin derivatives and compositions thereof
US6596717B2 (en) * 2000-12-21 2003-07-22 Aventis Pharma S.A. Streptogramin derivatives, their preparation and compositions which contain them
BRPI0418244A (pt) 2003-12-29 2007-04-17 Sepracor Inc composto, métodos para aumentar a concentração de d-serina e/ou diminuir a concentração de produtos tóxicos da oxidação de d-serina pela daao em um mamìfero, para tratar a esquizofrenia, para tratar ou prevenir a perda de memória e/ou cognição associadas com o mal de alzheimer, para tratar a ataxia ou para prevenir a perda da função neuronal caracterìstica de doenças neurodegenerativas, para intensificar a aprendizagem, memória e/ou cognição e para tratar dor neuropática, e, composição farmacêutica
US7565200B2 (en) * 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
ES2566479T3 (es) 2006-01-06 2016-04-13 Sunovion Pharmaceuticals Inc. Inhibidores de reabsorción de monoamina con base en tetralona
NZ569630A (en) 2006-01-06 2011-09-30 Sepracor Inc Cycloalkylamines as monoamine reuptake inhibitors
EP2816024B8 (en) 2006-03-31 2018-04-04 Sunovion Pharmaceuticals Inc. Chiral amines
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
RU2470011C2 (ru) 2007-05-31 2012-12-20 Сепракор Инк. Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов
CN103508981A (zh) * 2012-06-18 2014-01-15 北京美倍他药物研究有限公司 新的哌嗪衍生物及其医药用途
WO2019028084A1 (en) * 2017-08-01 2019-02-07 The Regents Of The University Of California METHODS OF PREPARING STREPTOGRAMINE COMPOSITIONS AND USE THEREOF
KR102107659B1 (ko) 2018-12-07 2020-05-07 경상대학교 산학협력단 Mmagnu1 화합물을 유효성분으로 함유하는 결핵균 또는 비결핵 항산균 감염 질환 예방 또는 치료용 조성물
AU2021279243A1 (en) 2020-05-27 2023-01-05 Fondazione Giovanni Celeghin - Onlus New therapy for the treatment of tumors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
BE1001013A4 (fr) 1987-10-22 1989-06-13 Icp Internat Inst Of Cellular Derives de synergimycines de types a et b, procede pour leur preparation et utilisation de ceux-ci.
IL121821A (en) * 1993-02-17 2000-02-17 Rhone Poulenc Rorer Sa Process for purifying a group A minority component of streptogramin some such purified components and their uses
FR2766489B1 (fr) * 1997-07-28 1999-08-27 Rhone Poulenc Rorer Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent
FR2795733B1 (fr) * 1999-06-30 2001-09-07 Aventis Pharma Sa Derives de streptogramines, leur preparation et les compositions qui les contiennent

Also Published As

Publication number Publication date
SK285605B6 (sk) 2007-04-05
AP2001002371A0 (en) 2001-12-31
NZ516100A (en) 2004-01-30
TNSN00145A1 (fr) 2002-05-30
GEP20063972B (en) 2006-11-27
US7166594B2 (en) 2007-01-23
AP1392A (en) 2005-04-15
CA2376698A1 (fr) 2001-01-11
SK19302001A3 (sk) 2002-07-02
HUP0201692A3 (en) 2002-10-28
KR100742035B1 (ko) 2007-07-23
EA005199B1 (ru) 2004-12-30
CN1358194A (zh) 2002-07-10
AR066926A2 (es) 2009-09-23
CN1961878A (zh) 2007-05-16
CZ20014641A3 (cs) 2002-04-17
EE200100706A (et) 2003-04-15
HRP20010937A2 (en) 2003-08-31
US20030149004A1 (en) 2003-08-07
BR0012032A (pt) 2002-03-19
EP1187847A1 (fr) 2002-03-20
AU781923B2 (en) 2005-06-23
JP2003503509A (ja) 2003-01-28
BG65786B1 (bg) 2009-11-30
DK1187847T3 (da) 2004-01-05
YU89501A (sh) 2004-05-12
MA26802A1 (fr) 2004-12-20
TR200103829T2 (tr) 2002-04-22
WO2001002427A1 (fr) 2001-01-11
HRP20010937B1 (en) 2005-02-28
AR029758A1 (es) 2003-07-16
OA11979A (fr) 2006-04-18
CN100543032C (zh) 2009-09-23
CZ301048B6 (cs) 2009-10-21
KR20020020763A (ko) 2002-03-15
DE60006958T2 (de) 2004-10-21
PL352781A1 (en) 2003-09-08
NO20016247D0 (no) 2001-12-19
NO329456B1 (no) 2010-10-25
FR2795733B1 (fr) 2001-09-07
SI1187847T1 (en) 2004-04-30
AU6288600A (en) 2001-01-22
ES2207535T3 (es) 2004-06-01
DE60006958D1 (de) 2004-01-15
EA200200108A1 (ru) 2002-06-27
CA2376698C (fr) 2013-05-14
EE04683B1 (et) 2006-08-15
ZA200110150B (en) 2003-03-10
MXPA01012807A (es) 2002-07-22
JP4585728B2 (ja) 2010-11-24
UA71619C2 (uk) 2004-12-15
IL146185A (en) 2007-08-19
NO20016247L (no) 2002-02-08
EP1187847B1 (fr) 2003-12-03
PT1187847E (pt) 2004-04-30
IL146185A0 (en) 2002-07-25
US6569854B1 (en) 2003-05-27
HUP0201692A2 (en) 2002-09-28
RS50138B (sr) 2009-03-25
BRPI0012032B1 (pt) 2015-06-30
ATE255592T1 (de) 2003-12-15
FR2795733A1 (fr) 2001-01-05

Similar Documents

Publication Publication Date Title
BG106235A (bg) Производни на стрептограмини, тяхното получаване и състави, които ги съдържат
IL124537A0 (en) Naphthyl-substituted benzimidazole derivatives and pharmaceutical compositions containing the same
AU2001264474A1 (en) Admantane derivatives
NO20025821L (no) 2-aminokarbonyl-9H-purinderivater
HK1036931A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients.
AU4264396A (en) Cosmetic or pharmaceutical compositions containing mangiferin or derivatives thereof
AU7535798A (en) Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
AU3504393A (en) N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
YU68199A (sh) Farmaceutske formulacije koje sadrže vorikonazol
YU19002A (sh) Derivati hinolil-propil-piperidina, njihovo dobivanje i smeše koje ih sadrže
IL108520A0 (en) Imidazopyridine derivatives, processes for the preparation thereof, and pharmaceutical compositions containing them
BG103947A (bg) Производни на 9-оксимеритромицин
AU3492100A (en) Oxadiazole compounds and compositions for delivering active agents
MXPA03008215A (es) Inhibidores de integrina alfa v beta 6.
HK1009139A1 (en) New 6-hydroxy and 6-oxo-androstane derivatives active on the cardiovascular system and pharmaceutical compositions containing same
AU7270798A (en) Antithrombotic agents
IL114968A (en) 1,4-dihydropyridine compounds and pharmaceutical compositions containing them
HU9600758D0 (en) Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption
ZA981430B (en) Anticancer composition
IL114719A0 (en) N-substituted azabicycloheptane derivatives their preparation and use thereof
ZA935045B (en) Pharmacologically active alfa-(tertiary-aminomethyl)-ben-zenemethanol derivatives
AU4609701A (en) Colouring agent for keratin containing fibres
IL134194A0 (en) Streptogramines, their preparation and compositions containing them
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use